Could a Three-Drug combo beat back recurrent breast cancer?
Disease control
Recruiting now
This study is for people with a type of breast cancer called triple-negative that has come back after treatment. The researchers want to see if adding a drug called bevacizumab to the usual combination of pembrolizumab and paclitaxel works better. About 44 adults who have already…
Phase: PHASE2 • Sponsor: Yukinori Ozaki • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC